{'fraction_non_alphanumeric': 0.026845637583892617, 'fraction_numerical': 0.01476510067114094, 'mean_word_length': 5.26890756302521, 'pattern_counts': {'":': 0, '<': 0, '<?xml version=': 0, '>': 0, 'https://': 0, 'lorem ipsum': 0, 'www.': 0, 'xml': 0}, 'pii_count': 0, 'substrings_counts': 0, 'word_list_counts': {'cursed_substrings.json': 0, 'profanity_word_list.json': 0, 'sexual_word_list.json': 0, 'zh_pornsignals.json': 0}}
[Treatment of emotional and cognitive disorders in patients with chronic cerebral ischemia].

OBJECTIVE
To study clinical efficacy of the drug divasa in patients with chronic cerebral ischemia.


MATERIAL AND METHODS
One hundred and forty-two patients, mean age 58,6±8,8 years, were treated during 11,9±0,2 weeks. Neurological examination and evaluation of a patient's status with psychometric scales were performed.


RESULTS
The drug reduced anxiety, depressive and asthenic disorders beginning from the 4th week of treatment. The positive effect of treatment on cognitive functions appeared later.


CONCLUSION
Divasa proved to be an effective drug in the complex treatment of patients with chronic disturbances of cerebral blood circulation.